Article
Fitness cost of chromosomal drug resistance-conferring mutations.
Antimicrobial agents and chemotherapy - 1 May 2002
Sander Peter, Springer Burkhard, Prammananan Therdsak, Sturmfels Antje, Kappler Martin, Pletschette Michel, Böttger Erik C
Abstract excerpt
To study the cost of chromosomal drug resistance mutations to bacteria, we investigated the fitness cost of mutations that confer resistance to different classes of antibiotics affecting bacterial protein synthesis (aminocyclitols, 2-deoxystreptamines, macrolides). We used a model system based on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
